Clinical Trial Clarity
Drug makers and regulators are taking steps towards transparency, but is it enough?
Charlotte Barker |
Pressure is mounting to expand reporting of clinical trials. The AllTrials initiative (www.alltrials.net) – a coalition of 600-plus publishers, charities and funding bodies – is calling for “all past and present clinical trials to be registered and their full methods and summary results reported.” Recently joined by a group of 85 asset managers and pension funds, the initiative is lobbying drug makers to make more data available. New European legislation will make it mandatory to report new trial data in a public database, following the example of clinicaltrials.gov in the US.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine